Accessibility navigation


Effect of viral load on the outcome of herpes zoster

Quinlivan, M. L., Ayres, K., Ran, H., McElwaine, S., Leedham-Green, M., Scott, F. T., Johnson, R. W. and Breuer, J. (2007) Effect of viral load on the outcome of herpes zoster. Journal of Clinical Microbiology, 45 (12). pp. 3909-3914. ISSN 0095-1137

Full text not archived in this repository.

To link to this article DOI: 10.1128/jcm.00874-07

Abstract/Summary

Varicella-zoster virus (VZV) is a member of the Herpesviridae family, primary infection with which causes varicella, more commonly known as chicken pox. Characteristic of members of the alphaherpesvirus subfamily, VZV is neurotropic and establishes latency in sensory neurons. Reactivation of VZV causes herpes zoster, also known as shingles. The most frequent complication following zoster is chronic and often debilitating pain called postherpetic neuralgia (PHN), which can last for months after the disappearance of a rash. During episodes of acute zoster, VZV viremia occurs in some, but not all, patients; however, the effect of the viral load on the disease outcome is not known. Here we describe the development of a highly specific, sensitive, and reproducible real-time PCR assay to investigate the factors that may contribute to the presence and levels of baseline viremia in patients with zoster and to determine the relationship between viremia and the development and persistence of PHN. VZV DNA was detected in the peripheral blood mononuclear cells (PBMCs) of 78% of patients with acute zoster and in 9% of healthy asymptomatic blood donors. The presence of VZV in the PBMCs of patients with acute zoster was independently associated with age and being on antivirals but not with gender, immune status, extent of rash, the age of the rash at the time of blood sampling, having a history of prodromal pain, or the extent of acute pain. Prodromal pain was significantly associated with higher baseline viral loads. Viral load levels were not associated with the development or persistence of PHN at 6, 12, or 26 weeks.

Item Type:Article
Refereed:Yes
Divisions:Faculty of Science > School of Mathematical and Physical Sciences > Department of Mathematics and Statistics > Applied Statistics
ID Code:10073
Uncontrolled Keywords:BLOOD MONONUCLEAR-CELLS, POSTHERPETIC NEURALGIA, VIRUS-DNA, VARICELLA, NOCICEPTORS, ACYCLOVIR, THERAPY, VIREMIA, PAIN, PCR

Centaur Editors: Update this record

Page navigation